Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |